TELIX Pharmaceuticals Ltd (TLX) — Financial Flexibility Index
TELIX Pharmaceuticals Ltd (TLX) has a Financial Flexibility Index of 0.05x as of June 2025. Free cash flow of AU$38.11 Million (operating CF AU$27.98 Million minus capex AU$10.13 Million) represents 0% of total liabilities (AU$768.01 Million). Check total reinvestment intensity of TELIX Pharmaceuticals Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TELIX Pharmaceuticals Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for TELIX Pharmaceuticals Ltd across 8 annual periods. For the full cash flow conversion analysis, see TLX operating cash flow.
Annual Financial Flexibility Index for TELIX Pharmaceuticals Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for TELIX Pharmaceuticals Ltd. Explore TLX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | AU$77.06 Million | AU$43.03 Million | AU$948.22 Million | ▼ -41.6% |
| 2023 | 0.14x | AU$34.68 Million | AU$23.88 Million | AU$249.39 Million | ▲ +149.5% |
| 2022 | -0.28x | AU$-50.11 Million | AU$-63.97 Million | AU$178.44 Million | ▲ +48.6% |
| 2021 | -0.55x | AU$-57.99 Million | AU$-59.33 Million | AU$106.17 Million | ▼ -1986.2% |
| 2020 | 0.03x | AU$2.28 Million | AU$1.96 Million | AU$78.81 Million | ▲ +104.0% |
| 2019 | -0.72x | AU$-22.86 Million | AU$-23.33 Million | AU$31.88 Million | ▲ +16.1% |
| 2018 | -0.85x | AU$-20.34 Million | AU$-20.75 Million | AU$23.80 Million | ▲ +74.5% |
| 2017 | -3.35x | AU$-6.03 Million | AU$-6.03 Million | AU$1.80 Million | — |